CytoMed Therapeutics Ltd

GDTC

Company Profile

  • Business description

    CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

  • Contact

    1 Commonwealth Lane
    No. 08-22 One Commonwealth
    Singapore149544
    SGP

    T: +65 62507738

    https://w2.cytomed.sg

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    42

Stocks News & Analysis

stocks

What a wobby AI trade could mean for Anthropic's IPO

Despite recent AI jitters, strategists expect strong demand for Anthropic’s potentially historic IPO.
stocks

Investor Playbook: What Transurban, APA and Deterra have in common?

What inflation-resistant businesses have in common.
stocks

Our view after REA’s share price rally

A bullish market reaction but valuation concerns remain.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,163.4018.700.20%
CAC 408,233.3094.301.16%
DAX 4026,267.19446.831.73%
Dow JONES (US)52,357.271,071.542.09%
FTSE 10010,782.87108.931.02%
HKSE24,448.9532.91-0.13%
NASDAQ25,196.90617.472.51%
Nikkei 22558,775.501,340.732.33%
NZX 50 Index13,973.6224.88-0.18%
S&P 5007,542.28165.422.24%
S&P/ASX 2009,029.708.900.10%
SSE Composite Index3,660.7911.610.32%

Market Movers